Rollins valuation gap widens as Nasdaq Composite backdrop shifts
Rollins was trading around US$47.77 after recent volatility, while a valuation narrative put fair value at $19.63, leaving the stock under close review by investors watching the nasdaq composite. Esteban said the gap reflected a discounted cash flow style framework built around the company’s recurring business.
Esteban’s $19.63 valuation
Esteban wrote that Rollins is “the dominant pure-play compounder in global pest control, a structurally necessary, recession-resistant service business that has grown revenue for 24 consecutive years and delivered ROIC of 23 to 31% for 12 consecutive years, without a single year of ROIC below 21% even through COVID-19.” The narrative used that record to arrive at a fair value of $19.63 and labeled the stock overvalued.
The same framework said Rollins generated revenue of US$3.8b and net income of US$529.3m. It also said the company produced $678M in free cash flow in FY2025 on $3.76B of revenue.
Rollins trading at $47.77
Rollins last closed at $47.77 after a 1-day share price return of 0.5% and a 7-day return of 4.3%. The stock was down 9.7% over 30 days and 19.1% year to date, even after a 5-year total shareholder return of 53.7%.
The valuation narrative pointed to several features of the business that support its model: commercial customers cannot switch providers without triggering compliance risk, residential customers renew habitually at annual price increases of 3 to 4% above CPI without meaningful churn, and Rollins completes 30 to 45 bolt-on acquisitions annually. It also said the fragmented U.S. pest control industry has more than 34,000 operators.
Margins and route density
The friction in the valuation case is in the assumptions behind it. The narrative said acquisition returns weakening or regulatory shifts in pest control could pressure margins and route density assumptions, which would feed directly into the discounted cash flow result.
For investors, that leaves a simple choice: accept the business quality arguments and pay close to the market price, or use the $19.63 estimate as a warning that Rollins already trades well ahead of the narrative’s fair value.
